M Cecilia Berin1, Daniel Lozano-Ojalvo2, Charuta Agashe2, Mary Grace Baker2, J Andrew Bird3, Anna Nowak-Wegrzyn4. 1. Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: cecilia.berin@mssm.edu. 2. Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY. 3. Department of Pediatrics, Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas, Tex. 4. Department of Pediatrics, New York University Grossman School of Medicine, Hassenfeld Children's Hospital, New York, NY; Department of Pediatrics, Gastroenterology and Nutrition, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.
Abstract
BACKGROUND: Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE-mediated food allergy characterized by profuse vomiting within hours of ingestion of the causative food. We have previously reported that FPIES is associated with systemic innate immune activation in the absence of a detectable antigen-specific antibody or T-cell response. The mechanism of specific food recognition by the immune system remains unclear. OBJECTIVE: Our aim was to identify immune mechanisms underlying FPIES reactions by proteomic and flow cytometric analysis of peripheral blood. METHODS: Children with a history of FPIES underwent supervised oral food challenge. Blood samples were taken at baseline, at symptom onset, and 4 hours after symptom onset. We analyzed samples from 23 children (11 reactors and 12 outgrown). A total of 184 protein markers were analyzed by proximity ligation assay and verified by multiplex immunoassay. Analysis of cell subset activation was performed by mass cytometry and spectral cytometry. RESULTS: Symptomatic FPIES challenge results were associated with significant elevation of levels of cytokines and chemokines, including IL-17 family markers (IL-17A, IL-22, IL-17C, and CCL20) and T-cell activation (IL-2), and innate inflammatory markers (IL-8, oncostatin M, leukemia inhibitory factor, TNF-α, IL-10, and IL-6). The level of the mucosal damage marker regenerating family member 1 alpha (REG1A) was also significantly increased. These biomarkers were not increased in asymptomatic challenges or IgE-mediated allergy. The level of phospho-STAT3 was significantly elevated in myeloid and T cells after challenge in individuals with symptoms. Mass cytometry indicated preferential activation of nonconventional T-cell populations, including γδ T cells and CD3+CD4-CD8-CD161+ cells; however, the potential sources of IL-17 in PBMCs were primarily CD4+ TH17 cells. CONCLUSIONS: These results demonstrate a unique IL-17 signature and activation of innate lymphocytes in FPIES.
BACKGROUND: Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE-mediated food allergy characterized by profuse vomiting within hours of ingestion of the causative food. We have previously reported that FPIES is associated with systemic innate immune activation in the absence of a detectable antigen-specific antibody or T-cell response. The mechanism of specific food recognition by the immune system remains unclear. OBJECTIVE: Our aim was to identify immune mechanisms underlying FPIES reactions by proteomic and flow cytometric analysis of peripheral blood. METHODS: Children with a history of FPIES underwent supervised oral food challenge. Blood samples were taken at baseline, at symptom onset, and 4 hours after symptom onset. We analyzed samples from 23 children (11 reactors and 12 outgrown). A total of 184 protein markers were analyzed by proximity ligation assay and verified by multiplex immunoassay. Analysis of cell subset activation was performed by mass cytometry and spectral cytometry. RESULTS: Symptomatic FPIES challenge results were associated with significant elevation of levels of cytokines and chemokines, including IL-17 family markers (IL-17A, IL-22, IL-17C, and CCL20) and T-cell activation (IL-2), and innate inflammatory markers (IL-8, oncostatin M, leukemia inhibitory factor, TNF-α, IL-10, and IL-6). The level of the mucosal damage marker regenerating family member 1 alpha (REG1A) was also significantly increased. These biomarkers were not increased in asymptomatic challenges or IgE-mediated allergy. The level of phospho-STAT3 was significantly elevated in myeloid and T cells after challenge in individuals with symptoms. Mass cytometry indicated preferential activation of nonconventional T-cell populations, including γδ T cells and CD3+CD4-CD8-CD161+ cells; however, the potential sources of IL-17 in PBMCs were primarily CD4+ TH17 cells. CONCLUSIONS: These results demonstrate a unique IL-17 signature and activation of innate lymphocytes in FPIES.
Authors: David Chiang; Xintong Chen; Stacie M Jones; Robert A Wood; Scott H Sicherer; A Wesley Burks; Donald Y M Leung; Charuta Agashe; Alexander Grishin; Peter Dawson; Wendy F Davidson; Leah Newman; Robert Sebra; Miriam Merad; Hugh A Sampson; Bojan Losic; M Cecilia Berin Journal: J Allergy Clin Immunol Date: 2018-01-31 Impact factor: 10.793
Authors: M Cecilia Berin; Alexander Grishin; Madhan Masilamani; Donald Y M Leung; Scott H Sicherer; Stacie M Jones; A Wesley Burks; Alice K Henning; Peter Dawson; Joanna Grabowska; Charuta Agashe; Wendy F Davidson; Robert A Wood; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2018-03-05 Impact factor: 10.793
Authors: Anna Nowak-Węgrzyn; Mirna Chehade; Marion E Groetch; Jonathan M Spergel; Robert A Wood; Katrina Allen; Dan Atkins; Sami Bahna; Ashis V Barad; Cecilia Berin; Terri Brown Whitehorn; A Wesley Burks; Jean-Christoph Caubet; Antonella Cianferoni; Marisa Conte; Carla Davis; Alessandro Fiocchi; Kate Grimshaw; Ruchi Gupta; Brittany Hofmeister; J B Hwang; Yitzhak Katz; George N Konstantinou; Stephanie A Leonard; Jennifer Lightdale; Sean McGhee; Sami Mehr; Stefano Miceli Sopo; Giovanno Monti; Antonella Muraro; Stacey Katherine Noel; Ichiro Nomura; Sally Noone; Hugh A Sampson; Fallon Schultz; Scott H Sicherer; Cecilia C Thompson; Paul J Turner; Carina Venter; A Amity Westcott-Chavez; Matthew Greenhawt Journal: J Allergy Clin Immunol Date: 2017-02-04 Impact factor: 10.793
Authors: Jean Christoph Caubet; Ramon Bencharitiwong; Andrew Ross; Hugh A Sampson; M Cecilia Berin; Anna Nowak-Węgrzyn Journal: J Allergy Clin Immunol Date: 2016-07-15 Impact factor: 10.793
Authors: Jean Christoph Caubet; Lara Simone Ford; Laura Sickles; Kirsi M Järvinen; Scott H Sicherer; Hugh A Sampson; Anna Nowak-Węgrzyn Journal: J Allergy Clin Immunol Date: 2014-05-28 Impact factor: 10.793
Authors: Raquel Bartolomé-Casado; Ole J B Landsverk; Sudhir Kumar Chauhan; Frank Sætre; Kjersti Thorvaldsen Hagen; Sheraz Yaqub; Ole Øyen; Rune Horneland; Einar Martin Aandahl; Lars Aabakken; Espen S Bækkevold; Frode L Jahnsen Journal: Mucosal Immunol Date: 2020-06-22 Impact factor: 7.313
Authors: Sebastian A Jensen; Alessandro Fiocchi; Ton Baars; Galateja Jordakieva; Anna Nowak-Wegrzyn; Isabella Pali-Schöll; Stefano Passanisi; Christina L Pranger; Franziska Roth-Walter; Kristiina Takkinen; Amal H Assa'ad; Carina Venter; Erika Jensen-Jarolim Journal: World Allergy Organ J Date: 2022-09-15 Impact factor: 5.516